$ cat ./records/funded-the-africa-cdc-to-build-the-continents-scientific-disease--2017.txt
Funded the Africa CDC to build the continent's scientific disease surveillance and response capacity
[RECORD.TXT] · cat --full
The Gates Foundation was a founding partner and major funder of the Africa Centres for Disease Control and Prevention — established by the African Union in 2017 to give Africa its own scientific public health agency modeled on the U.S. CDC. Foundation funding supported the Africa CDC's disease surveillance networks, laboratory capacity, genomic sequencing infrastructure, and emergency response protocols. During COVID-19, the Africa CDC became the primary continental coordinator of testing, genomic surveillance, and vaccine rollout — demonstrating the value of the long-term institutional investment Gates had championed.
Source: https://africacdc.org/
Free forever · No ads · Solo developer
If this was worth a read, help make the next entry possible.
Every entry in this archive was researched, verified, and written by one person — for free. No corporate funding. No ad revenue. Just a developer who believes verified history should be accessible to everyone. Your donation directly funds new entries.
Crypto accepted · No subscription required
← Previous
Funds Harvard Solar Geoengineering Research Program
Next →
Obama delivered keynote at the inaugural Gates Foundation Goalkeepers event
[CROSS_REFERENCES] · grep --category='Global Health'
Related Accomplishments
January 2026
Gates-backed World Mosquito Program reaches 16 million people protected from dengue via Wolbachia method
The World Mosquito Program — backed in part by the Gates Foundation — announced in January 2026 that its Wolbachia-infected mosquito releases had reached over 16.1 million people across multiple countries, including Colombia, Indonesia, Brazil, Sri Lanka, Fiji, Vanuatu, and Vietnam. Wolbachia-carrying Aedes aegypti mosquitoes — which block dengue, Zika, chikungunya, and yellow fever transmission — had established self-sustaining populations in treated cities without requiring ongoing releases. Gold-standard randomised trials in Indonesia showed a 77% reduction in dengue incidence. The program represented one of the largest and most cost-effective vector control deployments in history.
2025
Gates-Funded Monoclonal Antibody Shows Early Promise as a Single-Shot Malaria Shield
[ARCHIVE_FUNDING] · INDEPENDENT · NO ADS
One developer. >300 verified entries. Zero ads. Forever free.
No sponsors, no paywall, no algorithm. If this archive has been useful to you, reader support is what keeps it running.